bevacizumab
roche
['ovarian', 'gyn', 'beva', 'bevacizumab']
 addition of bevacizumab to standard chemotherapy in #clearcell #ovariancancer yields improved progression free and overall survival in a small retrospective study. improving treatment of this high risk and rare subtype is an unmet need in #gyncsm #asco22 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc